Apel Daniel Joseph
SEC insider (Form 3/4/5 filer). CIK 0002081169. Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 22, 2026. Located in PASADENA, CA.
Companies Apel Daniel Joseph has filed insider reports for
- ARROWHEAD PHARMACEUTICALS, INC. (ARWR): Officer, Chief Financial Officer
Apel Daniel Joseph
CIK: 0002081169
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (75.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 22, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect3.2K shares at avg. $70.11$225K - Apr 22, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect1.2K shares at avg. $70.45$82K - Apr 22, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
SaleDirect8.7K shares at avg. $71.92$628K - Jan 6, 2026ARWR
ARROWHEAD PHARMACEUTICALS, INC.
AwardDirect75K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 22, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 3,208 | $70.11 | $224,913 | Direct |
| Apr 22, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 1,157 | $70.45 | $81,511 | Direct |
| Apr 22, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Sale | 8,730 | $71.92 | $627,862 | Direct |
| Jan 6, 2026 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | Award | 75,000 | - | $0 | Direct |
1-4 of 4 transactions